Jan‐Henning Klusmann
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hematology 46
- Acute Myeloid Leukemia Research 42
- Hematopoietic Stem Cell Transplantation 11
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 10
- Co-authors
- Dirk ReinhardtSusann BlüherPeter SchwarzStephan EmmrichFrank J. GodinhoUrsula CreutzigStuart H. OrkinDirk Heckl
- Journals
- Blood (21 papers)Leukemia (6 papers)Frontiers in Immunology (5 papers)Haematologica (3 papers)Blood Advances (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Jan‐Henning Klusmann
82 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Hematology 1.2k
- Cancer Research 728
- Genetics 282
- Public Health, Environmental and Occupational Health 765
- Molecular Biology 1.5k
Countries citing papers authored by Jan‐Henning Klusmann
This map shows the geographic impact of Jan‐Henning Klusmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Henning Klusmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Henning Klusmann more than expected).
Fields of papers citing papers by Jan‐Henning Klusmann
This network shows the impact of papers produced by Jan‐Henning Klusmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Henning Klusmann. The network helps show where Jan‐Henning Klusmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan‐Henning Klusmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 11 | |
| 11 | 2021 | 24 | |
| 12 | 2018 | 146 | |
| 13 | Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications Hit paper breakdown → | 2017 | 196 |
| 14 | 2014 | 122 | |
| 15 | 2013 | 72 | |
| 16 | 2012 | 4 | |
| 17 | 2012 | 95 | |
| 18 | 2012 | 27 | |
| 19 | 2010 | 47 | |
| 20 | 2010 | 105 |
About Jan‐Henning Klusmann
Jan‐Henning Klusmann is a scholar working on Hematology, Cancer Research, Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, having authored 91 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (12 papers), MicroRNA in disease regulation (11 papers), Hematopoietic Stem Cell Transplantation (11 papers), Protein Degradation and Inhibitors (10 papers), Cancer-related molecular mechanisms research (10 papers), Epigenetics and DNA Methylation (8 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Hematology (1.2k citations), Cancer Research (728 citations), Genetics (282 citations), Public Health, Environmental and Occupational Health (765 citations) and Molecular Biology (1.5k citations). Jan‐Henning Klusmann has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Dirk Reinhardt, Susann Blüher, Peter Schwarz, Stephan Emmrich, Frank J. Godinho, Ursula Creutzig, Stuart H. Orkin, Dirk Heckl, Michael Dworzak and Zhe Li. Their work appears in journals such as Blood, Leukemia, Frontiers in Immunology, Haematologica and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.